Roles of tau protein in health and disease
暂无分享,去创建一个
Wendy Noble | Tong Guo | W. Noble | D. Hanger | Diane P. Hanger | Tong Guo
[1] J. Ávila,et al. Tau Protein and Adult Hippocampal Neurogenesis , 2012, Front. Neurosci..
[2] A. Hill,et al. Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner , 2016, The Journal of Biological Chemistry.
[3] T. Ohm,et al. Coupling of Mammalian Target of Rapamycin with Phosphoinositide 3-Kinase Signaling Pathway Regulates Protein Phosphatase 2A- and Glycogen Synthase Kinase-3β-dependent Phosphorylation of Tau* , 2008, Journal of Biological Chemistry.
[4] M. Goedert,et al. Like prions: the propagation of aggregated tau and &agr;-synuclein in neurodegeneration , 2017, Brain : a journal of neurology.
[5] Hyun-Jeong Cho,et al. DYRK1A-mediated Hyperphosphorylation of Tau , 2007, Journal of Biological Chemistry.
[6] I. Ferrer,et al. Tau‐positive nuclear indentations in P301S tauopathy mice , 2017, Brain pathology.
[7] N. Hirokawa,et al. Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons , 1992, Nature.
[8] Khadija Iqbal,et al. Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. , 1993, The Journal of biological chemistry.
[9] A J Lees,et al. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration , 2005, Journal of Medical Genetics.
[10] I. Grundke‐Iqbal,et al. Dephosphorylation of Tau by Protein Phosphatase 5 , 2005, Journal of Biological Chemistry.
[11] M. Polymeropoulos,et al. Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the α-synuclein gene , 2005, Acta Neuropathologica.
[12] B. Hyman,et al. Are Tangles as Toxic as They Look? , 2011, Journal of Molecular Neuroscience.
[13] Khadija Iqbal,et al. Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. , 1998, Archives of biochemistry and biophysics.
[14] E. Mandelkow,et al. Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines , 2010, The Journal of Neuroscience.
[15] C. Yuan,et al. Intrinsic Tau Acetylation Is Coupled to Auto-Proteolytic Tau Fragmentation , 2016, PloS one.
[16] M. Vitek,et al. Function of tau protein in adult newborn neurons , 2009, FEBS letters.
[17] G. Drewes,et al. The frontotemporal dementia mutation R406W blocks tau’s interaction with the membrane in an annexin A2–dependent manner , 2011, The Journal of cell biology.
[18] B. Hyman,et al. Nigral and Cortical Lewy Bodies and Dystrophic Nigral Neurites in Parkinson's Disease and Cortical Lewy Body Disease Contain α-synuclein Immunoreactivity , 1998, Journal of neuropathology and experimental neurology.
[19] M. Ciotti,et al. Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models , 2008, Molecular and Cellular Neuroscience.
[20] C. Geula,et al. Selective tau tyrosine nitration in non-AD tauopathies , 2011, Acta Neuropathologica.
[21] R. A. Crowther,et al. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.
[22] S. Fujita,et al. Inhibition of Protein Phosphatase 2A Overrides Tau Protein Kinase I/Glycogen Synthase Kinase 3β and Cyclin-dependent Kinase 5 Inhibition and Results in Tau Hyperphosphorylation in the Hippocampus of Starved Mouse* , 2001, The Journal of Biological Chemistry.
[23] Kazuyuki Takata,et al. Cdk5 Is a Key Factor in Tau Aggregation and Tangle Formation In Vivo , 2003, Neuron.
[24] E. Mandelkow,et al. Tau missorting and spastin-induced microtubule disruption in neurodegeneration: Alzheimer Disease and Hereditary Spastic Paraplegia , 2015, Molecular Neurodegeneration.
[25] K. Ye,et al. Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseases , 2016, Expert opinion on therapeutic targets.
[26] P. Mcgeer,et al. Thrombin accumulation in brains of patients with Alzheimer's disease , 1992, Neuroscience Letters.
[27] Jennifer Luebke,et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation , 2015, Nature Neuroscience.
[28] Ana Martins,et al. A Powerful Yeast Model to Investigate the Synergistic Interaction of α-Synuclein and Tau in Neurodegeneration , 2013, PloS one.
[29] A. Goldberg,et al. Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling , 2015, Nature Medicine.
[30] G. Werstuck,et al. Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3 , 2005, Journal of Cell Science.
[31] R. Malenka,et al. A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of Aβ on synapses and dendritic spines. , 2012, Human molecular genetics.
[32] H. Akiyama,et al. Glial Tau Pathology in Neurodegenerative Diseases: Their Nature and Comparison with Neuronal Tangles , 1998, Neurobiology of Aging.
[33] A. Andreadis,et al. Pathogenic Forms of Tau Inhibit Kinesin-Dependent Axonal Transport through a Mechanism Involving Activation of Axonal Phosphotransferases , 2011, The Journal of Neuroscience.
[34] Neurosci Lett , 2019 .
[35] G. Schellenberg,et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.
[36] Christian Griesinger,et al. The “Jaws” of the Tau-Microtubule Interaction* , 2007, Journal of Biological Chemistry.
[37] R. Nixon,et al. The role of autophagy in neurodegenerative disease , 2013, Nature Medicine.
[38] Y. Ihara,et al. Molecular aging of tau: disulfide‐independent aggregation and non‐enzymatic degradation in vitro and in vivo , 2004, Journal of neurochemistry.
[39] J. Woodgett,et al. The active form of glycogen synthase kinase-3β is associated with granulovacuolar degeneration in neurons in Alzheimer's disease , 2002, Acta Neuropathologica.
[40] T. Shea. Phospholipids alter tau conformation, phosphorylation, proteolysis, and association with microtubules: Implication for tau function under normal and degenerative conditions , 1997, Journal of neuroscience research.
[41] E. Mandelkow,et al. The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments. , 2008, Biochemistry.
[42] C. López-Otín,et al. Tau-related protein present in paired helical filaments has a decreased tubulin binding capacity as compared with microtubule-associated protein tau. , 1991, Biochimica et biophysica acta.
[43] Qian-Qian Jiang,et al. Region-specific expression of tau, amyloid-β protein precursor, and synaptic proteins at physiological condition or under endoplasmic reticulum stress in rats. , 2014, Journal of Alzheimer's disease : JAD.
[44] Val Lowe,et al. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. , 2013, Brain : a journal of neurology.
[45] F. Foufelle,et al. New insights into ER stress-induced insulin resistance , 2012, Trends in Endocrinology & Metabolism.
[46] Shoji Komai,et al. Characterization of Fyn-mediated Tyrosine Phosphorylation Sites on GluRε2 (NR2B) Subunit of theN-Methyl-d-aspartate Receptor* , 2001, The Journal of Biological Chemistry.
[47] H. Braak,et al. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads , 2004, Acta Neuropathologica.
[48] E. Mandelkow,et al. Interaction of tau protein with model lipid membranes induces tau structural compaction and membrane disruption. , 2012, Biochemistry.
[49] A. Goldberg,et al. cAMP-induced phosphorylation of 26S proteasomes on Rpn6/PSMD11 enhances their activity and the degradation of misfolded proteins , 2015, Proceedings of the National Academy of Sciences.
[50] U. Landegren,et al. Elevated MARK2-dependent phosphorylation of Tau in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[51] E. Mandelkow,et al. Swimming against the Tide: Mobility of the Microtubule-Associated Protein Tau in Neurons , 2007, The Journal of Neuroscience.
[52] J. Brion,et al. Reduction of acetylated alpha-tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer's disease. , 1996, Journal of neuropathology and experimental neurology.
[53] A. Delacourte,et al. Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization. , 2003, Biochimica et biophysica acta.
[54] Wendy Noble,et al. Tau phosphorylation affects its axonal transport and degradation , 2013, Neurobiology of Aging.
[55] Stephen B. Dunnett,et al. Characterization of Progressive Motor Deficits in Mice Transgenic for the Human Huntington’s Disease Mutation , 1999, The Journal of Neuroscience.
[56] F. J. Sullivan,et al. Molecular phenotyping of aging in single yeast cells using a novel microfluidic device , 2012, Aging cell.
[57] Manjit,et al. Neurology , 1912, NeuroImage.
[58] E. Marra,et al. A peptide containing residues 26-44 of tau protein impairs mitochondrial oxidative phosphorylation acting at the level of the adenine nucleotide translocator. , 2008, Biochimica et biophysica acta.
[59] Qian-Qian Jiang,et al. LiCl attenuates thapsigargin-induced tau hyperphosphorylation by inhibiting GSK-3β in vivo and in vitro. , 2010, Journal of Alzheimer's disease : JAD.
[60] S. Hébert,et al. Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease. , 2015, Human molecular genetics.
[61] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[62] H. Paudel,et al. 14-3-3ζ Is an Effector of Tau Protein Phosphorylation* , 2000, The Journal of Biological Chemistry.
[63] R. Nixon,et al. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[64] D. Rubinsztein,et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. , 2006, Human molecular genetics.
[65] G. Glenner,et al. Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[66] R. Ravid,et al. DC11: a novel monoclonal antibody revealing Alzheimer's disease-specific tau epitope , 2003, Neuroreport.
[67] A. Ittner,et al. Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice , 2011, PloS one.
[68] R. Jope,et al. Central Role of Glycogen Synthase Kinase-3β in Endoplasmic Reticulum Stress-induced Caspase-3 Activation* , 2002, The Journal of Biological Chemistry.
[69] M. Vitek,et al. Tau deficiency leads to the upregulation of BAF‐57, a protein involved in neuron‐specific gene repression , 2010, FEBS letters.
[70] C. Hetz,et al. Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases , 2014, Nature Reviews Neuroscience.
[71] A. Ittner. SITE-SPECIFIC PHOSPHORYLATION OF TAU INHIBITS AMYLOID-β TOXICITY IN ALZHEIMER’S MICE , 2016, Alzheimer's & Dementia.
[72] C. Barbato,et al. Tau Cleavage and Dephosphorylation in Cerebellar Granule Neurons Undergoing Apoptosis , 1998, The Journal of Neuroscience.
[73] M. Pool,et al. Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein. , 2001 .
[74] B. Hyman,et al. Tangle-Bearing Neurons Survive Despite Disruption of Membrane Integrity in a Mouse Model of Tauopathy , 2009, Journal of neuropathology and experimental neurology.
[75] E. Mandelkow,et al. Proteolytic processing of tau. , 2010, Biochemical Society transactions.
[76] M. Hayden,et al. Inhibition of Calpain Cleavage of Huntingtin Reduces Toxicity , 2004, Journal of Biological Chemistry.
[77] C. Oliveira,et al. A novel DYRK1A (Dual specificity tyrosine phosphorylation‐regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro , 2015, Journal of neurochemistry.
[78] M. Zvelebil,et al. Phosphorylation Regulates Tau Interactions with Src Homology 3 Domains of Phosphatidylinositol 3-Kinase, Phospholipase Cγ1, Grb2, and Src Family Kinases* , 2008, Journal of Biological Chemistry.
[79] M. Meraz-Ríos,et al. Tau oligomers and aggregation in Alzheimer’s disease , 2010, Journal of neurochemistry.
[80] Jun Wang,et al. Paired Helical Filaments from Alzheimer Disease Brain Induce Intracellular Accumulation of Tau Protein in Aggresomes* , 2012, The Journal of Biological Chemistry.
[81] Max L. Valenstein,et al. Graded Control of Microtubule Severing by Tubulin Glutamylation , 2016, Cell.
[82] L. Mucke,et al. Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.
[83] R. Brandt,et al. Systemic and network functions of the microtubule-associated protein tau: Implications for tau-based therapies , 2017, Molecular and Cellular Neuroscience.
[84] P. Højrup,et al. α-Synuclein Binds to Tau and Stimulates the Protein Kinase A-catalyzed Tau Phosphorylation of Serine Residues 262 and 356* , 1999, The Journal of Biological Chemistry.
[85] J. Clarimón,et al. Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy , 2011, PloS one.
[86] I. Mansuy,et al. The memory gene KIBRA is a bidirectional regulator of synaptic and structural plasticity in the adult brain , 2016, Neurobiology of Learning and Memory.
[87] M. Weiner,et al. Genome-wide association study identifies MAPT locus influencing human plasma tau levels , 2017, Neurology.
[88] S. Lorenzl,et al. Increased α-synuclein aggregation following limited cleavage by certain matrix metalloproteinases , 2009, Experimental Neurology.
[89] R. Nitsch,et al. Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.
[90] D. Bennett,et al. Early N-Terminal Changes and Caspase-6 Cleavage of Tau in Alzheimer's Disease , 2004, The Journal of Neuroscience.
[91] M. Radeke,et al. Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly. , 1997, Molecular biology of the cell.
[92] F. García-Sierra,et al. Accumulation of Aspartic Acid421- and Glutamic Acid391-Cleaved Tau in Neurofibrillary Tangles Correlates With Progression in Alzheimer Disease , 2008, Journal of neuropathology and experimental neurology.
[93] A. Fagan,et al. Fine Mapping of Genetic Variants in BIN1, CLU, CR1 and PICALM for Association with Cerebrospinal Fluid Biomarkers for Alzheimer's Disease , 2011, PloS one.
[94] T. Tabira,et al. The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties. , 2015, Human molecular genetics.
[95] D. Dickson,et al. Colocalization of Tau and Alpha‐Synuclein Epitopes in Lewy Bodies , 2003, Journal of neuropathology and experimental neurology.
[96] D. Selkoe,et al. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders , 1987, Annals of neurology.
[97] L. Blanchoin,et al. Tau co-organizes dynamic microtubule and actin networks , 2015, Scientific Reports.
[98] Andrew J. Payne,et al. Caspase-3-Dependent Proteolytic Cleavage of Tau Causes Neurofibrillary Tangles and Results in Cognitive Impairment During Normal Aging , 2016, Neurochemical Research.
[99] D. Dickson,et al. An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies , 2006, Acta Neuropathologica.
[100] M. Ciotti,et al. Endogenous Aβ causes cell death via early tau hyperphosphorylation , 2011, Neurobiology of Aging.
[101] E. Mandelkow,et al. Linking Amyloid-β and Tau: Amyloid-β Induced Synaptic Dysfunction via Local Wreckage of the Neuronal Cytoskeleton , 2011, Neurodegenerative Diseases.
[102] F. Polleux,et al. The CAMKK2-AMPK Kinase Pathway Mediates the Synaptotoxic Effects of Aβ Oligomers through Tau Phosphorylation , 2013, Neuron.
[103] L. Grinberg,et al. Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies , 2014, Neuron.
[104] H. Akiyama,et al. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration , 2003, Acta Neuropathologica.
[105] R. He,et al. The proline-rich domain of tau plays a role in interactions with actin , 2009, BMC Cell Biology.
[106] L. Buée,et al. Ectosomes: A New Mechanism for Non-Exosomal Secretion of Tau Protein , 2014, PloS one.
[107] S. Yen,et al. Degradation of Tau by Lysosomal Enzyme Cathepsin D: Implication for Alzheimer Neurofibrillary Degeneration , 1997, Journal of neurochemistry.
[108] E. Mandelkow,et al. Autophagic degradation of tau in primary neurons and its enhancement by trehalose , 2012, Neurobiology of Aging.
[109] J. Kuret,et al. Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases , 2000, Neurobiology of Aging.
[110] A. Roses,et al. ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation , 1995, Neuroscience Letters.
[111] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[112] S. Brady. Mice overexpressing the human neurofilament heavy gene as a model of ALS , 1995, Neurobiology of Aging.
[113] E. Bigio,et al. Calpain-Mediated Tau Cleavage: A Mechanism Leading to Neurodegeneration Shared by Multiple Tauopathies , 2011, Molecular medicine.
[114] J. Trojanowski,et al. Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice , 2015, Neurobiology of Disease.
[115] J. Trojanowski,et al. The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice , 2012, The Journal of Neuroscience.
[116] F. Tagliavini,et al. A new function of microtubule-associated protein tau: Involvement in chromosome stability , 2008, Cell cycle.
[117] G. Bloom. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. , 2014, JAMA neurology.
[118] G. Schellenberg,et al. Tau isoform regulation is region‐ and cell‐specific in mouse brain , 2008, The Journal of comparative neurology.
[119] E. Mandelkow,et al. Degradation of tau protein by autophagy and proteasomal pathways. , 2012, Biochemical Society transactions.
[120] L. Buée,et al. Loss of Tau protein affects the structure, transcription and repair of neuronal pericentromeric heterochromatin , 2016, Scientific Reports.
[121] D. Constam,et al. Cloning of the Human Puromycin‐Sensitive Aminopeptidase and Evidence for Expression in Neurons , 1997, Journal of neurochemistry.
[122] H. Steinhoff,et al. Global hairpin folding of tau in solution. , 2006, Biochemistry.
[123] Stefani N. Thomas,et al. Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity. , 2014, The Biochemical journal.
[124] V. Lee,et al. The microtubule-associated tau protein has intrinsic acetyltransferase activity , 2013, Nature Structural &Molecular Biology.
[125] E. Mandelkow,et al. Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. , 2009, Human molecular genetics.
[126] J. Trojanowski,et al. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.
[127] L. Hersh,et al. Studies on the Tissue Distribution of the Puromycin‐Sensitive Enkephalin‐Degrading Aminopeptidases , 1988, Journal of neurochemistry.
[128] H. Wiśniewski,et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[129] M. Mattson,et al. Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.
[130] I. Landrieu,et al. Structural impact of heparin binding to full-length Tau as studied by NMR spectroscopy. , 2006, Biochemistry.
[131] A. Andreadis. Misregulation of tau alternative splicing in neurodegeneration and dementia. , 2006, Progress in molecular and subcellular biology.
[132] David W. Colby,et al. Conformational features of tau fibrils from Alzheimer's disease brain are faithfully propagated by unmodified recombinant protein. , 2013, Biochemistry.
[133] W. Markesbery,et al. Impaired Proteasome Function in Alzheimer's Disease , 2000, Journal of neurochemistry.
[134] Ralph A. Nixon,et al. Autophagy Induction and Autophagosome Clearance in Neurons: Relationship to Autophagic Pathology in Alzheimer's Disease , 2008, The Journal of Neuroscience.
[135] W. Noble,et al. Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau , 2011, The FEBS journal.
[136] J. Trojanowski,et al. Epitopes that span the tau molecule are shared with paired helical filaments , 1988, Neuron.
[137] K. Arima,et al. NACP/α-synuclein and tau constitute two distinctive subsets of filaments in the same neuronal inclusions in brains from a family of parkinsonism and dementia with Lewy bodies: double-immunolabeling fluorescence and electron microscopic studies , 2000, Acta Neuropathologica.
[138] E. Mandelkow,et al. Tau protein and tau aggregation inhibitors , 2010, Neuropharmacology.
[139] J. Trojanowski,et al. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer’s disease or corticobasal degeneration brains , 2015, Acta Neuropathologica.
[140] David H. Cribbs,et al. Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome , 2004, Neuron.
[141] Tim Scholz,et al. Tau Protein Diffuses along the Microtubule Lattice* , 2012, The Journal of Biological Chemistry.
[142] E. Seto,et al. Lysine acetylation: codified crosstalk with other posttranslational modifications. , 2008, Molecular cell.
[143] Li-Huei Tsai,et al. Aberrant Cdk5 Activation by p25 Triggers Pathological Events Leading to Neurodegeneration and Neurofibrillary Tangles , 2003, Neuron.
[144] C. Duyckaerts,et al. The microtubule-associated protein tau is also phosphorylated on tyrosine. , 2009, Journal of Alzheimer's disease : JAD.
[145] Frank M LaFerla,et al. A novel BACE1-regulating protein with therapeutic potential , 2012, Alzheimer's & Dementia.
[146] Mark Turmaine,et al. Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.
[147] Ying Liu,et al. Amyloid-like aggregates of neuronal tau induced by formaldehyde promote apoptosis of neuronal cells , 2007, BMC Neuroscience.
[148] G. Schellenberg,et al. A distinct familial presenile dementia with a novel missense mutation in the tau gene. , 1999, Neuroreport.
[149] Richard Hollister,et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease , 1997, Annals of neurology.
[150] A. Lees,et al. The Slow Axonal Transport of the Microtubule-Associated Protein Tau and the Transport Rates of Different Isoforms and Mutants in Cultured Neurons , 2002, The Journal of Neuroscience.
[151] D. Hanger,et al. Tau cleavage and tau aggregation in neurodegenerative disease. , 2010, Biochemical Society transactions.
[152] S. Lipton,et al. Synaptic Protein α1-Takusan Mitigates Amyloid-β-Induced Synaptic Loss via Interaction with Tau and Postsynaptic Density-95 at Postsynaptic Sites , 2013, The Journal of Neuroscience.
[153] M. Navarrete,et al. Novel function of Tau in regulating the effects of external stimuli on adult hippocampal neurogenesis , 2016, The EMBO journal.
[154] E. Mandelkow,et al. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress , 2002, The Journal of cell biology.
[155] R. Huber,et al. HTRA proteases: regulated proteolysis in protein quality control , 2011, Nature Reviews Molecular Cell Biology.
[156] J. Götz,et al. Mobility and subcellular localization of endogenous, gene-edited Tau differs from that of over-expressed human wild-type and P301L mutant Tau , 2016, Scientific Reports.
[157] Kenneth S. Kosik,et al. Developmentally regulated expression of specific tau sequences , 1989, Neuron.
[158] D. Hanger,et al. Functional implications of the association of tau with the plasma membrane. , 2010, Biochemical Society transactions.
[159] D. Geschwind,et al. A Genomic Screen for Modifiers of Tauopathy Identifies Puromycin-Sensitive Aminopeptidase as an Inhibitor of Tau-Induced Neurodegeneration , 2006, Neuron.
[160] P. Cohen,et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.
[161] Naruhiko Sahara,et al. Propagation of Tau Pathology in a Model of Early Alzheimer's Disease , 2012, Neuron.
[162] Nigel J. Cairns,et al. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies , 1998, Neuroscience Letters.
[163] Michel Goedert,et al. Mutations causing neurodegenerative tauopathies. , 2005, Biochimica et biophysica acta.
[164] H. Onoe,et al. Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice , 2011, Neurobiology of Disease.
[165] Gloria Lee. Tau and src family tyrosine kinases. , 2005, Biochimica et biophysica acta.
[166] L. Christophorou. Science , 2018, Emerging Dynamics: Science, Energy, Society and Values.
[167] L. Buée,et al. Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo , 2015, Neurobiology of Disease.
[168] H. Wille,et al. Conformational Diversity of Wild-type Tau Fibrils Specified by Templated Conformation Change* , 2009, Journal of Biological Chemistry.
[169] J. Trojanowski,et al. Acetylated tau neuropathology in sporadic and hereditary tauopathies. , 2013, The American journal of pathology.
[170] B. Saccà,et al. Determinants of amyloid fibril degradation by the PDZ protease HTRA1. , 2015, Nature chemical biology.
[171] M. Baudry,et al. Tyrosine phosphorylation of ionotropic glutamate receptors by Fyn or Src differentially modulates their susceptibility to calpain and enhances their binding to spectrin and PSD‐95 , 2001, Journal of neurochemistry.
[172] Ruth Nussinov,et al. Structural Insight into Tau Protein’s Paradox of Intrinsically Disordered Behavior, Self-Acetylation Activity, and Aggregation , 2014, The journal of physical chemistry letters.
[173] B. Hyman,et al. Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.
[174] E. Mandelkow,et al. Amyloid‐β oligomers induce synaptic damage via Tau‐dependent microtubule severing by TTLL6 and spastin , 2013, The EMBO journal.
[175] G. V. Van Hoesen,et al. Phosphorylation of Tau by Fyn: Implications for Alzheimer's Disease , 2004, The Journal of Neuroscience.
[176] M. Hemberg,et al. Tau promotes neurodegeneration through global chromatin relaxation , 2014, Nature Neuroscience.
[177] E. Mandelkow,et al. Tau in physiology and pathology , 2015, Nature Reviews Neuroscience.
[178] Tsuyoshi Morita,et al. Specification of Neuronal Polarity Regulated by Local Translation of CRMP2 and Tau via the mTOR-p70S6K Pathway* , 2009, The Journal of Biological Chemistry.
[179] George Perry,et al. Activation of p38 Kinase Links Tau Phosphorylation, Oxidative Stress, and Cell Cycle‐Related Events in Alzheimer Disease , 2000 .
[180] C. Jack,et al. Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias , 2014, Alzheimer's Research & Therapy.
[181] P. Waters. Fragile Y Chromosomes (retrospective on DOI 10.1002/bies.201500040) , 2017, BioEssays : news and reviews in molecular, cellular and developmental biology.
[182] H. Braak,et al. Alzheimer’s pathogenesis: is there neuron-to-neuron propagation? , 2011, Acta Neuropathologica.
[183] S. Counts,et al. Pseudophosphorylation of tau at S422 enhances SDS-stable dimer formation and impairs both anterograde and retrograde fast axonal transport , 2016, Experimental Neurology.
[184] K. Kosik,et al. Competition for microtubule-binding with dual expression of tau missense and splice isoforms. , 2001, Molecular biology of the cell.
[185] J. Bamburg,et al. Neurodegenerative stimuli induce persistent ADF/cofilin–actin rods that disrupt distal neurite function , 2000, Nature Cell Biology.
[186] Min Jae Lee,et al. Tau degradation: The ubiquitin–proteasome system versus the autophagy-lysosome system , 2013, Progress in Neurobiology.
[187] J. Lancia,et al. Tau oligomers and tau toxicity in neurodegenerative disease. , 2012, Biochemical Society transactions.
[188] C. Troakes,et al. Prostate-derived Sterile 20-like Kinases (PSKs/TAOKs) Phosphorylate Tau Protein and Are Activated in Tangle-bearing Neurons in Alzheimer Disease* , 2013, The Journal of Biological Chemistry.
[189] R. Llinás,et al. Tau pathology-mediated presynaptic dysfunction , 2016, Neuroscience.
[190] L. Behar,et al. Axonal Tau mRNA Localization Coincides with Tau Protein in Living Neuronal Cells and Depends on Axonal Targeting Signal , 2001, The Journal of Neuroscience.
[191] A. Buisson,et al. Activity-Dependent Tau Protein Translocation to Excitatory Synapse Is Disrupted by Exposure to Amyloid-Beta Oligomers , 2014, The Journal of Neuroscience.
[192] G M Cohen,et al. Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.
[193] John Hardy,et al. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation , 2004 .
[194] E. Mandelkow,et al. Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[195] M. Ciotti,et al. AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons , 2014, Neurobiology of Disease.
[196] D. Wilkin,et al. Neuron , 2001, Brain Research.
[197] F. Jin,et al. Alzheimer’s disease and gut microbiota , 2016, Science China Life Sciences.
[198] D. Hanger,et al. Reduced number of axonal mitochondria and tau hypophosphorylation in mouse P301L tau knockin neurons , 2016, Neurobiology of Disease.
[199] Christian Griesinger,et al. Structural Polymorphism of 441-Residue Tau at Single Residue Resolution , 2009, PLoS biology.
[200] J. Lucas,et al. Faulty splicing and cytoskeleton abnormalities in Huntington's disease , 2016, Brain pathology.
[201] R. Huber,et al. Human High Temperature Requirement Serine Protease A1 (HTRA1) Degrades Tau Protein Aggregates* , 2012, The Journal of Biological Chemistry.
[202] W. Scheper,et al. Endoplasmic reticulum: the unfolded protein response is tangled in neurodegeneration. , 2012, The international journal of biochemistry & cell biology.
[203] W. Noble,et al. Molecular motors implicated in the axonal transport of tau and α-synuclein , 2005, Journal of Cell Science.
[204] M. Mercken,et al. Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[205] J. Abisambra,et al. Tau accumulation activates the unfolded protein response by impairing endoplasmic reticulum-associated degradation , 2013, Alzheimer's & Dementia.
[206] N. Sousa,et al. Absence of Tau triggers age‐dependent sciatic nerve morphofunctional deficits and motor impairment , 2016, Aging cell.
[207] J. Ávila,et al. τ Protein from Alzheimer's Disease Patients Is Glycated at Its Tubulin‐Binding Domain , 1995, Journal of neurochemistry.
[208] P. Fraser. Prions and Prion-like Proteins , 2014, The Journal of Biological Chemistry.
[209] Khadija Iqbal,et al. Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease. , 2008, Current medicinal chemistry.
[210] Kazuhiro Oiwa,et al. Single‐molecule investigation of the interference between kinesin, tau and MAP2c , 2002, The EMBO journal.
[211] Cam Patterson,et al. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. , 2007, The Journal of clinical investigation.
[212] R. Wade-Martins. Genetics: The MAPT locus—a genetic paradigm in disease susceptibility , 2012, Nature Reviews Neurology.
[213] Keith A. Johnson,et al. Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging , 2015, Neuropathology and applied neurobiology.
[214] P. Dolan,et al. The role of tau kinases in Alzheimer's disease. , 2010, Current opinion in drug discovery & development.
[215] N. Zilka,et al. Misfolded Truncated Protein τ Induces Innate Immune Response via MAPK Pathway , 2011, The Journal of Immunology.
[216] I. Grundke‐Iqbal,et al. Site‐specific effects of tau phosphorylation on its microtubule assembly activity and self‐aggregation , 2007, The European journal of neuroscience.
[217] Hu Li,et al. Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity. , 2016, Cell reports.
[218] Casey Cook,et al. Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance , 2013, Human molecular genetics.
[219] J. Trojanowski,et al. Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein , 2003, Science.
[220] P. Verstreken,et al. Loss of Bin1 Promotes the Propagation of Tau Pathology. , 2016, Cell reports.
[221] J. Ávila,et al. Tau protein provides DNA with thermodynamic and structural features which are similar to those found in histone-DNA complex. , 2014, Journal of Alzheimer's disease : JAD.
[222] Mathias Jucker,et al. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases , 2013, Nature.
[223] R. Williams,et al. Microtubule-associated proteins connect microtubules and neurofilaments in vitro. , 1984, Biochemistry.
[224] J. Kordower,et al. Substantia nigra tangles are related to gait impairment in older persons , 2006, Annals of neurology.
[225] Wendy Noble,et al. Physiological release of endogenous tau is stimulated by neuronal activity , 2013, EMBO reports.
[226] S. Lovestone,et al. Effects of FTDP‐17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3β identified by mass spectrometry demonstrate certain mutations exert long‐range conformational changes , 2001, FEBS letters.
[227] R. Huganir,et al. Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer‐induced AMPA glutamate receptor signaling deficits , 2014, The European journal of neuroscience.
[228] Wen-Lang Lin,et al. Autophagic‐lysosomal perturbation enhances tau aggregation in transfectants with induced wild‐type tau expression , 2008, The European journal of neuroscience.
[229] Q. Tian,et al. Bip enhanced the association of GSK-3β with tau during ER stress both in vivo and in vitro. , 2012, Journal of Alzheimer's disease : JAD.
[230] K. Zahs,et al. Caspase-2 cleavage of tau reversibly impairs memory , 2016, Nature Medicine.
[231] I. Landrieu,et al. NMR investigation of the interaction between the neuronal protein tau and the microtubules. , 2007, Biochemistry.
[232] W. Scheper,et al. Unfolded protein response activates glycogen synthase kinase-3 via selective lysosomal degradation , 2013, Neurobiology of Aging.
[233] S. Hubbard,et al. How IRE1 Reacts to ER Stress , 2008, Cell.
[234] Akihiko Takashima,et al. Chaperones increase association of tau protein with microtubules , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[235] I. Grundke‐Iqbal,et al. Microtubule associated protein tau binds to double-stranded but not single-stranded DNA , 2003, Cellular and Molecular Life Sciences CMLS.
[236] E. Mandelkow,et al. Biochemistry and cell biology of tau protein in neurofibrillary degeneration. , 2012, Cold Spring Harbor perspectives in medicine.
[237] A. Ittner,et al. Tau‐targeted treatment strategies in Alzheimer's disease , 2012, British journal of pharmacology.
[238] R. Berry,et al. Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment. , 2003, Biochemistry.
[239] A. McKee,et al. Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease* , 2011, The Journal of Biological Chemistry.
[240] James L. Buescher,et al. Tau‐tubulin kinase 1 (TTBK1), a neuron‐specific tau kinase candidate, is involved in tau phosphorylation and aggregation , 2006, Journal of neurochemistry.
[241] S. Albrecht,et al. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease. , 2004, The American journal of pathology.
[242] T. Hortobágyi,et al. Evidence that the presynaptic vesicle protein CSPalpha is a key player in synaptic degeneration and protection in Alzheimer’s disease , 2015, Molecular Brain.
[243] W. Noble,et al. Dynamic association of tau with neuronal membranes is regulated by phosphorylation , 2012, Neurobiology of Aging.
[244] S. Prusiner. Novel proteinaceous infectious particles cause scrapie. , 1982, Science.
[245] A. Lees,et al. The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies , 2002, FEBS letters.
[246] J. Wu,et al. Specific processing of native and phosphorylated tau protein by proteases. , 1996, Biochemical and biophysical research communications.
[247] Meaghan Morris,et al. The Many Faces of Tau , 2011, Neuron.
[248] Steven P. Gygi,et al. CHIP-Hsc70 Complex Ubiquitinates Phosphorylated Tau and Enhances Cell Survival* , 2004, Journal of Biological Chemistry.
[249] D. Rubinsztein,et al. The roles of intracellular protein-degradation pathways in neurodegeneration , 2006, Nature.
[250] C. Chirita,et al. Pathways of tau fibrillization. , 2005, Biochimica et biophysica acta.
[251] K. Tamura,et al. Stimulatory effect of α‐synuclein on the tau‐phosphorylation by GSK‐3β , 2011, The FEBS journal.
[252] W. Scheper,et al. The unfolded protein response in neurodegenerative diseases: a neuropathological perspective , 2015, Acta Neuropathologica.
[253] E. Masliah,et al. Mechanisms of synaptic dysfunction in Alzheimer's disease. , 1995, Histology and histopathology.
[254] M. Colin,et al. Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies , 2016, Acta neuropathologica communications.
[255] Qian Sun,et al. Tau phosphorylation by GSK-3β promotes tangle-like filament morphology , 2007, Molecular Neurodegeneration.
[256] P. Filipcik,et al. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load , 2008, The European journal of neuroscience.
[257] M. Xue,et al. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease , 2015, Oxidative medicine and cellular longevity.
[258] N. Leclerc,et al. Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma , 2016, The Journal of Neuroscience.
[259] L. Raymond,et al. Cleavage at the Caspase-6 Site Is Required for Neuronal Dysfunction and Degeneration Due to Mutant Huntingtin , 2006, Cell.
[260] R. Berry,et al. Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo , 2006, Journal of neurochemistry.
[261] Alfonso Baldi,et al. Implications of the serine protease HtrA1 in amyloid precursor protein processing , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[262] Xiaohong Zhou,et al. The proline-rich domain and the microtubule binding domain of protein tau acting as RNA binding domains. , 2006, Protein and peptide letters.
[263] C. Cotman,et al. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. , 2004, The Journal of clinical investigation.
[264] J. Trojanowski,et al. Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies* , 2009, Journal of Biological Chemistry.
[265] M. Novák. Truncated tau protein as a new marker for Alzheimer's disease. , 1994, Acta virologica.
[266] H. Vinters,et al. Pre‐synaptic C‐terminal truncated tau is released from cortical synapses in Alzheimer's disease , 2015, Journal of neurochemistry.
[267] G. Perry,et al. Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology. , 2016, Journal of Alzheimer's disease : JAD.
[268] E. Bird,et al. Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin , 1990, Brain Research.
[269] T. Arendt,et al. Tau and tauopathies , 2016, Brain Research Bulletin.
[270] V. Haroutunian,et al. Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy , 2010, Neuron.
[271] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[272] Fei Liu,et al. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation , 2005, The European journal of neuroscience.
[273] E. Roberson,et al. The dendritic hypothesis for Alzheimer's disease pathophysiology , 2014, Brain Research Bulletin.
[274] I. Correas,et al. The tubulin-binding sequence of brain microtubule-associated proteins, tau and MAP-2, is also involved in actin binding. , 1990, The Biochemical journal.
[275] Ayodeji A. Asuni,et al. Immunotherapy Targeting Pathological Tau Conformers in a Tangle Mouse Model Reduces Brain Pathology with Associated Functional Improvements , 2007, The Journal of Neuroscience.
[276] M. Sudol,et al. The importance of being proline: the interaction of proline‐rich motifs in signaling proteins with their cognate domains , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[277] G. Lynch,et al. Cytosolic Proteolysis of τ by Cathepsin D in Hippocampus Following Suppression of Cathepsins B and L , 1996, Journal of neurochemistry.
[278] I. Ferrer,et al. Huntington's disease is a four-repeat tauopathy with tau nuclear rods , 2014, Nature Medicine.
[279] P. Reddy,et al. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. , 2011, Human molecular genetics.
[280] F. Tagliavini,et al. Mutations in MAPT gene cause chromosome instability and introduce copy number variations widely in the genome. , 2013, Journal of Alzheimer's disease : JAD.
[281] J. Trojanowski,et al. Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies , 2013, Nature Reviews Neuroscience.
[282] C. Cotman,et al. Caspase-9 Activation and Caspase Cleavage of tau in the Alzheimer's Disease Brain , 2002, Neurobiology of Disease.
[283] Irving E. Vega,et al. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates. , 2005, Brain research. Molecular brain research.
[284] J. Miklossy,et al. Thrombin and Prothrombin Are Expressed by Neurons and Glial Cells and Accumulate in Neurofibrillary Tangles in Alzheimer Disease Brain , 2006, Journal of neuropathology and experimental neurology.
[285] D. Xia,et al. Pseudophosphorylation of Tau at distinct epitopes or the presence of the P301L mutation targets the microtubule-associated protein Tau to dendritic spines. , 2015, Biochimica et biophysica acta.
[286] E. Mandelkow,et al. Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model , 2007, Proceedings of the National Academy of Sciences.
[287] P. Baas,et al. Microtubules in health and degenerative disease of the nervous system , 2016, Brain Research Bulletin.
[288] C. Zurzolo,et al. Small Misfolded Tau Species Are Internalized via Bulk Endocytosis and Anterogradely and Retrogradely Transported in Neurons* , 2012, The Journal of Biological Chemistry.
[289] Jürgen Götz,et al. Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.
[290] Nancy Ratner,et al. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin‐based motility , 2002, The EMBO journal.
[291] Sangmook Lee,et al. Interneuronal transfer of human tau between Lamprey central neurons in situ. , 2010, Journal of Alzheimer's disease : JAD.
[292] E. Huang,et al. Argyrophilic grain disease differs from other tauopathies by lacking tau acetylation , 2013, Acta Neuropathologica.
[293] M. Farrer,et al. MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy , 2011, Neurology.
[294] J. Götz,et al. Phosphorylated Tau Interacts with c-Jun N-terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease* , 2009, The Journal of Biological Chemistry.
[295] G. Drewes,et al. Tau interactome mapping based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo , 2017, Acta Neuropathologica.
[296] I. Grundke‐Iqbal,et al. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration , 2007, The European journal of neuroscience.
[297] L. Buée,et al. Nuclear magnetic resonance spectroscopy characterization of interaction of Tau with DNA and its regulation by phosphorylation. , 2015, Biochemistry.
[298] F. Brodsky,et al. Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds , 2013, Proceedings of the National Academy of Sciences.
[299] Jian-Zhi Wang,et al. SIL1 Rescued Bip Elevation-Related Tau Hyperphosphorylation in ER Stress , 2015, Molecular Neurobiology.
[300] Menno P. Witter,et al. Trans-Synaptic Spread of Tau Pathology In Vivo , 2012, PloS one.
[301] Wendy Noble,et al. Tyrosine 394 Is Phosphorylated in Alzheimer's Paired Helical Filament Tau and in Fetal Tau with c-Abl as the Candidate Tyrosine Kinase , 2005, The Journal of Neuroscience.
[302] W. Poon,et al. Caspase-Cleaved Tau Co-Localizes with Early Tangle Markers in the Human Vascular Dementia Brain , 2015, PloS one.
[303] R. Nitsch,et al. Proteasome inhibition by paired helical filament‐tau in brains of patients with Alzheimer's disease , 2003, Journal of neurochemistry.
[304] Xiongwei Zhu,et al. Phosphorylation of Tau Protein as the Link between Oxidative Stress, Mitochondrial Dysfunction, and Connectivity Failure: Implications for Alzheimer's Disease , 2013, Oxidative medicine and cellular longevity.
[305] T. Hortobágyi,et al. Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate , 2016, Brain : a journal of neurology.
[306] J. Trojanowski,et al. The acetylation of tau inhibits its function and promotes pathological tau aggregation. , 2011, Nature communications.
[307] G. Pasinetti,et al. Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro. , 2003, Biochimica et biophysica acta.
[308] Peter Tompa,et al. On the Sequential Determinants of Calpain Cleavage* , 2004, Journal of Biological Chemistry.
[309] G. Johnson,et al. Localization and in situ phosphorylation state of nuclear tau. , 1995, Experimental cell research.
[310] O. Levy,et al. The neuropathology of genetic Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[311] W. Scheper,et al. The unfolded protein response is associated with early tau pathology in the hippocampus of tauopathies , 2012, The Journal of pathology.
[312] A. Anderson,et al. Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer disease, and effect of postmortem tissue archival on TUNEL , 2000, Neurobiology of Aging.
[313] R. Zinkowski,et al. Presence of tau in isolated nuclei from human brain , 1995, Neurobiology of Aging.
[314] Dennis W. Dickson,et al. Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau) , 2011, Journal of Molecular Neuroscience.
[315] R. Huganir,et al. Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss , 2016, Neuron.
[316] C. Richter-Landsberg,et al. Expression of microtubule-associated proteins MAP2 and tau in cultured rat brain oligodendrocytes , 1997, Cell and Tissue Research.
[317] A. Klug,et al. Structural characterization of the core of the paired helical filament of Alzheimer disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[318] P. Cohen,et al. Molecular dissection of the paired helical filament , 1995, Neurobiology of Aging.
[319] Lynn A. Hyde,et al. Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology , 2015, Molecular Neurodegeneration.
[320] P. Szekeres,et al. Short Fibrils Constitute the Major Species of Seed-Competent Tau in the Brains of Mice Transgenic for Human P301S Tau , 2016, The Journal of Neuroscience.
[321] T. Wollert. Autophagy , 2019, Current Biology.
[322] A. Prokop,et al. Tau and spectraplakins promote synapse formation and maintenance through Jun kinase and neuronal trafficking , 2016, eLife.
[323] H. Band,et al. Tau interacts with src-family non-receptor tyrosine kinases. , 1998, Journal of cell science.
[324] G. Schmitt-Ulms,et al. The Human Tau Interactome: Binding to the Ribonucleoproteome, and Impaired Binding of the Proline-to-Leucine Mutant at Position 301 (P301L) to Chaperones and the Proteasome* , 2015, Molecular & Cellular Proteomics.
[325] K. Ashe,et al. Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration , 2010, Neuron.
[326] Luc Bracoud,et al. Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial , 2016, The Lancet.
[327] A. Giese,et al. Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level , 2012, Molecular Neurodegeneration.
[328] Siamak Shahidi,et al. BRAIN RES BULL , 2008 .
[329] M. Diamond,et al. Propagation of Tau Misfolding from the Outside to the Inside of a Cell* , 2009, Journal of Biological Chemistry.
[330] N. Hirokawa,et al. Gem GTPase and Tau , 2004, Journal of Biological Chemistry.
[331] G. Sancesario,et al. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration. , 2010, Journal of Alzheimer's disease : JAD.
[332] P. Davies,et al. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[333] V. Hu. The Cell Cycle , 1994, GWUMC Department of Biochemistry Annual Spring Symposia.
[334] J. Lambert,et al. Tau phosphorylation regulates the interaction between BIN1’s SH3 domain and Tau’s proline-rich domain , 2015, Acta Neuropathologica Communications.
[335] R. Chang,et al. Endoplasmic reticulum stress induces tau pathology and forms a vicious cycle: implication in Alzheimer's disease pathogenesis. , 2012, Journal of Alzheimer's disease : JAD.
[336] H. Vinters,et al. Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration , 2016, Proceedings of the National Academy of Sciences.
[337] Burton S. Rosner,et al. Neuropharmacology , 1958, Nature.
[338] K. Scearce-Levie,et al. Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement. , 2016, Cell reports.
[339] J. Götz,et al. Profiling Murine Tau with 0N, 1N and 2N Isoform-Specific Antibodies in Brain and Peripheral Organs Reveals Distinct Subcellular Localization, with the 1N Isoform Being Enriched in the Nucleus , 2013, PloS one.
[340] L. Buée,et al. Nuclear Tau, a Key Player in Neuronal DNA Protection* , 2010, The Journal of Biological Chemistry.
[341] A. Delacourte,et al. Tau protein as a differential biomarker of tauopathies. , 2005, Biochimica et biophysica acta.
[342] P. Davies,et al. Determination of peptide substrate specificity for mu-calpain by a peptide library-based approach: the importance of primed side interactions. , 2005, The Journal of biological chemistry.
[343] M. Vitek,et al. Tau is essential to β-amyloid-induced neurotoxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[344] F. Wouters,et al. α-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton , 2007, Neurobiology of Disease.
[345] E. Mandelkow,et al. Proline-directed Pseudo-phosphorylation at AT8 and PHF1 Epitopes Induces a Compaction of the Paperclip Folding of Tau and Generates a Pathological (MC-1) Conformation* , 2008, Journal of Biological Chemistry.
[346] P. Dolan,et al. Caspase-cleaved Tau Expression Induces Mitochondrial Dysfunction in Immortalized Cortical Neurons , 2009, The Journal of Biological Chemistry.
[347] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[348] G. Johnson,et al. Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. , 1992, The Journal of biological chemistry.
[349] F. Dahlquist,et al. A soluble oligomer of tau associated with fiber formation analyzed by NMR. , 2008, Biochemistry.
[350] S. Yen,et al. Disease-related Modifications in Tau Affect the Interaction between Fyn and Tau* , 2005, Journal of Biological Chemistry.
[351] Elisabeth L. Moussaud-Lamodière,et al. Alpha-synuclein and tau: teammates in neurodegeneration? , 2014, Molecular Neurodegeneration.
[352] K. Kosaka,et al. Occurrence of human α-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer’s disease , 2000, Journal of the Neurological Sciences.
[353] M. Hasegawa,et al. The Relationship Between Development of Neuronal and Astrocytic Tau Pathologies in Subcortical Nuclei and Progression of Argyrophilic Grain Disease , 2016, Brain pathology.
[354] M. Feany,et al. Lysosomal Dysfunction Promotes Cleavage and Neurotoxicity of Tau In Vivo , 2010, PLoS genetics.
[355] R. Morimoto,et al. Huntington's disease: underlying molecular mechanisms and emerging concepts. , 2013, Trends in biochemical sciences.
[356] Chuong B. Do,et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease , 2014, Nature Genetics.
[357] R. Hamilton,et al. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.
[358] L. Binder,et al. Phosphorylation determines two distinct species of Tau in the central nervous system. , 1987, Cell motility and the cytoskeleton.
[359] R. Berry,et al. Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[360] L. Buée,et al. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology. , 2010, Journal of Alzheimer's disease : JAD.
[361] A. Lang,et al. Interface between tauopathies and synucleinopathies: A tale of two proteins , 2006, Annals of neurology.
[362] A M Gronenborn,et al. Minor groove-binding architectural proteins: structure, function, and DNA recognition. , 1998, Annual review of biophysics and biomolecular structure.
[363] R. Rosenfeld. Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[364] T. Südhof,et al. CSPα knockout causes neurodegeneration by impairing SNAP‐25 function , 2012, The EMBO journal.
[365] P. Janmey,et al. The structure of divalent cation-induced aggregates of PIP2 and their alteration by gelsolin and tau. , 1997, Biophysical journal.
[366] P. Dolan,et al. Histone deacetylase 6 interacts with the microtubule‐associated protein tau , 2008, Journal of neurochemistry.
[367] Meaghan Morris,et al. Tau post-translational modifications in wildtype and human amyloid precursor protein transgenic mice , 2015, Nature Neuroscience.
[368] I. Grundke‐Iqbal,et al. Glycosylation of microtubule–associated protein tau: An abnormal posttranslational modification in Alzheimer's disease , 1996, Nature Medicine.
[369] S. Gauthier,et al. Paired helical filaments and the cytoplasmic-nuclear interface in Alzheimer's disease , 1988, Journal of neurocytology.
[370] P. Baráth,et al. N-terminal truncation of microtubule associated protein tau dysregulates its cellular localization. , 2014, Journal of Alzheimer's disease : JAD.
[371] A. Lang,et al. Neuronal degeneration, synaptic defects, and behavioral abnormalities in tau45-230 transgenic mice , 2014, Neuroscience.
[372] H. Akiyama,et al. Neurons containing Alz-50-immunoreactive granules around the cerebral infarction: evidence for the lysosomal degradation of altered tau in human brain? , 2000, Neuroscience Letters.
[373] E. Klann,et al. Macroautophagy deficiency mediates age-dependent neurodegeneration through a phospho-tau pathway , 2012, Molecular Neurodegeneration.
[374] Y. Liu,et al. Hyperphosphorylation results in tau dysfunction in DNA folding and protection. , 2013, Journal of Alzheimer's disease : JAD.
[375] Simone Lista,et al. Advances in the therapy of Alzheimer’s disease: targeting amyloid beta and tau and perspectives for the future , 2015, Expert review of neurotherapeutics.
[376] J. Kabat,et al. Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. , 1993, The EMBO journal.
[377] Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways , 2012, Journal of Neuroinflammation.
[378] M. Halliday,et al. PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia , 2015, Acta Neuropathologica.
[379] N. Leclerc,et al. Interaction of Endogenous Tau Protein with Synaptic Proteins Is Regulated by N-Methyl-d-aspartate Receptor-dependent Tau Phosphorylation* , 2012, The Journal of Biological Chemistry.
[380] U. Kang,et al. Membrane Depolarization Induces the Undulating Phosphorylation/Dephosphorylation of Glycogen Synthase Kinase 3β, and This Dephosphorylation Involves Protein Phosphatases 2A and 2B in SH-SY5Y Human Neuroblastoma Cells* , 2005, Journal of Biological Chemistry.
[381] L. Buée,et al. A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions , 2014, Front. Cell. Neurosci..
[382] I. Grundke‐Iqbal,et al. Promotion of Hyperphosphorylation by Frontotemporal Dementia Tau Mutations* , 2004, Journal of Biological Chemistry.
[383] J. M. Lee,et al. Tau phosphorylation increases in symptomatic mice overexpressing A30P α-synuclein , 2005, Experimental Neurology.
[384] T. Montine,et al. Proteomic Identification of Novel Proteins in Cortical Lewy Bodies , 2007, Brain pathology.
[385] A. Borreca,et al. NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer's disease. , 2015, Human molecular genetics.
[386] M. Diamond,et al. Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo , 2016, Neuron.
[387] R. Barker,et al. GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease: involvement of astrocyte–neuron interactions , 2016, Cell Death and Disease.
[388] Jürgen Götz,et al. Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia , 2008, Proceedings of the National Academy of Sciences.
[389] Xiongwei Zhu,et al. Tau – an inhibitor of deacetylase HDAC6 function , 2009, Journal of neurochemistry.
[390] A. Mietelska-Porowska,et al. Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction , 2014, International journal of molecular sciences.
[391] A. Grierson,et al. Role of axonal transport in neurodegenerative diseases. , 2008, Annual review of neuroscience.
[392] S. Yen,et al. Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy , 2010, Neuropathology and applied neurobiology.
[393] 廣瀬雄一,et al. Neuroscience , 2019, Workplace Attachments.
[394] G. Perry,et al. Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology , 2007, Neuropathology and applied neurobiology.
[395] F. Young. Biochemistry , 1955, The Indian Medical Gazette.
[396] T. Zalewska,et al. Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? , 1992, BioEssays : news and reviews in molecular, cellular and developmental biology.
[397] L. Binder,et al. Identification of nuclear tau isoforms in human neuroblastoma cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[398] R. D'Hooge,et al. Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion , 2014, Neurobiology of Aging.
[399] B. Liu,et al. Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src. , 2011, The Biochemical journal.
[400] A. Sidhu,et al. Tauopathic Changes in the Striatum of A53T α-Synuclein Mutant Mouse Model of Parkinson's Disease , 2011, PloS one.
[401] Youssra K Al-Hilaly,et al. Nuclear Tau and Its Potential Role in Alzheimer’s Disease , 2016, Biomolecules.
[402] P. Filipcik,et al. Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy , 2006, The European journal of neuroscience.
[403] E. Bigio,et al. Phosphorylation and cleavage of tau in non-AD tauopathies , 2007, Acta Neuropathologica.
[404] D. Selkoe,et al. Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration , 2011, Proceedings of the National Academy of Sciences.
[405] A. Morton,et al. Selective Discrimination Learning Impairments in Mice Expressing the Human Huntington's Disease Mutation , 1999, The Journal of Neuroscience.
[406] C. Koumenis,et al. The PERK/eIF2α/ATF4 module of the UPR in hypoxia resistance and tumor growth , 2006 .
[407] Alcino J. Silva,et al. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies , 2013, Aging cell.
[408] G. Perry,et al. Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymers , 2005, Molecular and Cellular Biochemistry.
[409] P. Mcgeer,et al. Proteolysis of Non-phosphorylated and Phosphorylated Tau by Thrombin* , 2005, Journal of Biological Chemistry.
[410] S. Sensi,et al. Alterations of brain and cerebellar proteomes linked to Aβ and tau pathology in a female triple-transgenic murine model of Alzheimer's disease , 2010, Cell Death and Disease.
[411] G. Collingridge,et al. Microtubule-associated protein tau is essential for long-term depression in the hippocampus , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.
[412] J. Ávila,et al. Polymerization of τ into Filaments in the Presence of Heparin: The Minimal Sequence Required for τ ‐ τ Interaction , 1996 .
[413] E. Masliah,et al. Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure , 2014, BMC Neuroscience.
[414] E. Braak,et al. Distribution, Levels, and Activity of Glycogen Synthase Kinase‐3 in the Alzheimer Disease Brain , 1997, Journal of neuropathology and experimental neurology.
[415] Yingfu Li,et al. Tau protein binds single‐stranded DNA sequence specifically – the proof obtained in vitro with non‐equilibrium capillary electrophoresis of equilibrium mixtures , 2005, FEBS letters.
[416] Q. Tian,et al. Essential role of tau phosphorylation in adult hippocampal neurogenesis , 2010, Hippocampus.
[417] L. Wilkinson. Immunity , 1891, The Lancet.
[418] K. Ye,et al. Human wild-type full-length tau accumulation disrupts mitochondrial dynamics and the functions via increasing mitofusins , 2016, Scientific Reports.
[419] R. Barbour,et al. Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease* , 2006, Journal of Biological Chemistry.
[420] P. Reddy,et al. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage. , 2012, Human molecular genetics.
[421] Ramesh Kandimalla,et al. Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis. , 2016, Biochimica et biophysica acta.
[422] R. Maccioni,et al. Tau protein binds to pericentromeric DNA: a putative role for nuclear tau in nucleolar organization , 2006, Journal of Cell Science.
[423] T. Iwatsubo,et al. Somatodendritic localization of phosphorylated tau in neonatal and adult rat cerebral cortex , 1997, Neuroreport.
[424] L. Buée,et al. Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms , 2015, Scientific Reports.
[425] J. Lucas,et al. Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome , 2016, Brain pathology.
[426] Jin-Tai Yu,et al. Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy , 2014, Neurobiology of Aging.
[427] W. Noble,et al. Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. , 2009, Trends in molecular medicine.
[428] K. Cain,et al. CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease. , 2015, Parkinsonism & related disorders.
[429] W Noble,et al. Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture , 2011, Cell Death and Disease.
[430] D. Wilson,et al. Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. , 1997, The American journal of pathology.
[431] J. Trojanowski,et al. Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies , 2009, Nature Reviews Drug Discovery.
[432] W. Scheper,et al. The unfolded protein response mediates reversible tau phosphorylation induced by metabolic stress , 2014, Cell Death and Disease.
[433] Jean-Pierre Julien,et al. Axonal transport deficits and neurodegenerative diseases , 2013, Nature Reviews Neuroscience.
[434] Yan-wen Zhang,et al. Tau protein is involved in morphological plasticity in hippocampal neurons in response to BDNF , 2012, Neurochemistry International.
[435] M. Saraste,et al. FEBS Lett , 2000 .
[436] J. Trotter,et al. Process Outgrowth of Oligodendrocytes Is Promoted by Interaction of Fyn Kinase with the Cytoskeletal Protein Tau , 2002, The Journal of Neuroscience.
[437] Kit-Yi Leung,et al. Novel Phosphorylation Sites in Tau from Alzheimer Brain Support a Role for Casein Kinase 1 in Disease Pathogenesis* , 2007, Journal of Biological Chemistry.
[438] E. Mandelkow,et al. Microtubule-associated Protein/Microtubule Affinity-regulating Kinase (p110mark) , 1995, The Journal of Biological Chemistry.
[439] M. Citron,et al. Constitutive secretion of tau protein by an unconventional mechanism , 2012, Neurobiology of Disease.
[440] N. Krogan,et al. Critical Role of Acetylation in Tau-Mediated Neurodegeneration and Cognitive Deficits , 2015, Nature Medicine.
[441] W. Scheper,et al. The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. , 2009, The American journal of pathology.
[442] H. Nagaraja,et al. Tau Isoform Composition Influences Rate and Extent of Filament Formation* , 2012, The Journal of Biological Chemistry.
[443] H. Akiyama,et al. Identification of amino‐terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration , 2004, Annals of neurology.
[444] Romana Höftberger,et al. Endoplasmic Reticulum Stress Features Are Prominent in Alzheimer Disease but Not in Prion Diseases In Vivo , 2006, Journal of neuropathology and experimental neurology.
[445] U. Sengupta,et al. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice , 2011, Molecular Neurodegeneration.
[446] G. Bloom,et al. Amyloid-&bgr; signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer's disease , 2013, Journal of Cell Science.
[447] J. Hardy,et al. Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP , 2001, Science.
[448] A. Sidhu,et al. Age-Dependent Effects of A53T Alpha-Synuclein on Behavior and Dopaminergic Function , 2013, PloS one.
[449] L. Serpell,et al. Proteasomal degradation of tau protein , 2002, Journal of neurochemistry.
[450] Jose Viña,et al. Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[451] L. McIntosh,et al. O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers. , 2014, Journal of molecular biology.
[452] M. Goedert,et al. Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. , 1990, The EMBO journal.
[453] S. Lovestone,et al. The Importance of Tau Phosphorylation for Neurodegenerative Diseases , 2013, Front. Neurol..
[454] G. Muntané,et al. Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer’s disease, and in Parkinson’s disease and related α-synucleinopathies , 2008, Neuroscience.
[455] C. Surridge,et al. The difference in the binding of phosphatidylinositol distinguishes MAP2 from MAP2C and Tau. , 1994, Biochemistry.
[456] M. Pérez,et al. Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer’s Disease , 2018, Molecular Neurobiology.
[457] M. Noble,et al. The microtubule binding domain of microtubule-associated protein MAP1B contains a repeated sequence motif unrelated to that of MAP2 and tau , 1989, The Journal of cell biology.
[458] J. Pasquini,et al. Defective ubiquitination of cerebral proteins in Alzheimer's disease , 2000, Journal of neuroscience research.
[459] I. Grundke‐Iqbal,et al. Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5 , 2002, Neuroscience.
[460] M. Cataldi,et al. Lysosomal dysfunction disrupts presynaptic maintenance and restoration of presynaptic function prevents neurodegeneration in lysosomal storage diseases , 2016, EMBO molecular medicine.
[461] W. Noble,et al. Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[462] R. Zinkowski,et al. A novel tau transcript in cultured human neuroblastoma cells expressing nuclear tau , 1993, The Journal of cell biology.
[463] E. Mandelkow,et al. Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. , 2002, Biochemistry.
[464] Tudor A. Fulga,et al. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo , 2007, Nature Cell Biology.
[465] B. Hyman,et al. Caspase activation precedes and leads to tangles , 2010, Nature.
[466] M. Goedert,et al. Interaction of tau protein with the dynactin complex , 2007, The EMBO journal.
[467] C. Harrington,et al. Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer’s disease , 1996, Acta Neuropathologica.
[468] M. Ban,et al. Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease , 2007 .
[469] P. Davies,et al. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms , 2003, Journal of neurochemistry.
[470] J. Woodgett,et al. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase , 1992, Neuroscience Letters.
[471] J. Brion,et al. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1 , 2004, Neurobiology of Disease.
[472] A. Peters,et al. Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain. , 2011, The American journal of pathology.
[473] G. Ugolini,et al. The Neuronal Microtubule‐Associated Protein Tau Is a Substrate for Caspase‐3 and an Effector of Apoptosis , 2000 .
[474] O. F. Olesen. Proteolytic degradation of microtubule associated protein tau by thrombin. , 1994, Biochemical and biophysical research communications.
[475] P. Davies,et al. Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models , 2011, The Journal of Biological Chemistry.
[476] P. Filipcik,et al. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo , 2006, FEBS letters.
[477] E. Mandelkow,et al. Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease , 1998, The Journal of cell biology.
[478] M. Diamond,et al. Tau Trimers Are the Minimal Propagation Unit Spontaneously Internalized to Seed Intracellular Aggregation* , 2015, The Journal of Biological Chemistry.
[479] Jason E Gestwicki,et al. Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo , 2012, Autophagy.
[480] E. Bigio,et al. Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease , 2005, Neurobiology of Aging.
[481] P. Filipcik,et al. First transgenic rat model developing progressive cortical neurofibrillary tangles , 2012, Neurobiology of Aging.
[482] K. Jellinger. Absence of α-synuclein pathology in postencephalitic parkinsonism , 2009, Acta Neuropathologica.
[483] Wen-Lang Lin,et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein , 2000, Nature Genetics.
[484] A. Andreadis,et al. Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport , 2012, Neurobiology of Aging.
[485] L. Mucke,et al. Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.
[486] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[487] Martin Beibel,et al. Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.
[488] J. Cho,et al. Glycogen Synthase Kinase 3 (cid:1) Induces Caspase-cleaved Tau Aggregation in Situ * , 2022 .
[489] I. Landrieu,et al. Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation. , 2011, Molecular bioSystems.
[490] J. Walker,et al. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[491] William T. Hu,et al. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer’s disease , 2014, Nature Medicine.
[492] Adriana B Ferreira,et al. The Neurotoxic Tau45-230 Fragment Accumulates in Upper and Lower Motor Neurons in Amyotrophic Lateral Sclerosis Subjects , 2016, Molecular medicine.
[493] S. Brady,et al. Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition , 2016, Neurobiology of Aging.
[494] R. Kayed,et al. The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration , 2015, Aging cell.
[495] W. Noble,et al. Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease , 2016, Acta Neuropathologica Communications.
[496] Adriana B Ferreira,et al. The Generation of a 17 kDa Neurotoxic Fragment: An Alternative Mechanism by which Tau Mediates β-Amyloid-Induced Neurodegeneration , 2005, The Journal of Neuroscience.
[497] T. Shea,et al. Phosphorylation of Tau Alters Its Association with the Plasma Membrane , 2000, Cellular and Molecular Neurobiology.
[498] N. Leclerc,et al. Increased Association Between Rough Endoplasmic Reticulum Membranes and Mitochondria in Transgenic Mice That Express P301L Tau , 2009, Journal of neuropathology and experimental neurology.
[499] L. Partridge,et al. Acetylation mimic of lysine 280 exacerbates human Tau neurotoxicity in vivo , 2016, Scientific Reports.
[500] D. Monard,et al. Prothrombin mRNA is expressed by cells of the nervous system , 1991, Neuron.
[501] L. Staudt,et al. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. , 2004, Immunity.
[502] A. Cattaneo,et al. Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[503] B. C. Carter,et al. Multiple-motor based transport and its regulation by Tau , 2007, Proceedings of the National Academy of Sciences.
[504] J. Ávila,et al. Thermodynamics of the Interaction between Alzheimer's Disease Related Tau Protein and DNA , 2014, PloS one.
[505] F. Terro,et al. Post-translational modifications of tau protein: Implications for Alzheimer's disease , 2011, Neurochemistry International.
[506] L. Grinberg,et al. Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment , 2016, Molecular Neurodegeneration.
[507] Maxime W. C. Rousseaux,et al. TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau , 2016, eLife.
[508] U. Sengupta,et al. Characterization of tau oligomeric seeds in progressive supranuclear palsy , 2014, Acta neuropathologica communications.
[509] M. Owen,et al. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology , 2013, Molecular Psychiatry.
[510] L. Gan,et al. Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss Increased levels of acetylated tau blocks the postsynaptic signaling required for plasticity and promotes memory deficits associated with tauopathy , 2017, BioEssays : news and reviews in molecular, cellular and developmental biology.
[511] J. Kuret,et al. C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. , 2000, Journal of cell science.
[512] D. Hanger,et al. Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N‐terminally cleaved tau containing four microtubule‐binding repeats , 2008, Journal of neurochemistry.
[513] Ram Dixit,et al. Differential Regulation of Dynein and Kinesin Motor Proteins by Tau , 2008, Science.
[514] H. Braak,et al. Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.
[515] Xiaomin Song,et al. Co-immunoprecipitation with Tau Isoform-specific Antibodies Reveals Distinct Protein Interactions and Highlights a Putative Role for 2N Tau in Disease , 2016, The Journal of Biological Chemistry.
[516] Sonja W. Scholz,et al. Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.
[517] R. Jope,et al. Proteolysis of tau by calpain. , 1989, Biochemical and biophysical research communications.
[518] R. Brandt,et al. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain , 1995, The Journal of cell biology.
[519] J. Freed,et al. Tau binds to lipid membrane surfaces via short amphipathic helices located in its microtubule-binding repeats. , 2014, Biophysical journal.
[520] J. Ávila,et al. Tau isoform with three microtubule binding domains is a marker of new axons generated from the subgranular zone in the hippocampal dentate gyrus: implications for Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.
[521] E. Sigurdsson,et al. Passive immunization targeting pathological phospho‐tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain , 2011, Journal of neurochemistry.
[522] Paul Greengard,et al. Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies , 2007, Proceedings of the National Academy of Sciences.
[523] T. Südhof,et al. CSPα promotes SNARE-complex assembly by chaperoning SNAP-25 during synaptic activity , 2011, Nature Cell Biology.
[524] F. LaFerla,et al. Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. , 2007, The American journal of pathology.
[525] O. Ross,et al. Association Studies of Sporadic Parkinson’s Disease in the Genomic Era , 2014, Current genomics.
[526] H. Huttunen,et al. Internalized Tau sensitizes cells to stress by promoting formation and stability of stress granules , 2016, Scientific Reports.
[527] T. Shea,et al. A 26–30 kDa developmentally-regulated tauisoform localized within nuclei of mitotic humanneuroblastoma cells , 1998, International Journal of Developmental Neuroscience.
[528] G. Hart,et al. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[529] C. Oliveira,et al. ER stress is involved in Aβ‐induced GSK‐3β activation and tau phosphorylation , 2008, Journal of neuroscience research.
[530] E. Mandelkow,et al. Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration , 2011, The EMBO journal.
[531] L. Petrucelli,et al. FTDP‐17 with Pick body‐like inclusions associated with a novel tau mutation, p.E372G , 2017, Brain pathology.
[532] D. Xia,et al. Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment , 2017, Acta Neuropathologica.
[533] J. Winn,et al. Brain , 1878, The Lancet.
[534] E. Mandelkow,et al. Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment , 2011, Neurobiology of Aging.
[535] D. Bennett,et al. The neuropathology of older persons with and without dementia from community versus clinic cohorts. , 2009, Journal of Alzheimer's disease : JAD.
[536] S. A. Hussaini,et al. Neuronal activity enhances tau propagation and tau pathology in vivo , 2016, Nature Neuroscience.
[537] M. Mercken,et al. Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF‐tau , 1995, FEBS letters.
[538] L. Buée,et al. Mutant huntingtin alters Tau phosphorylation and subcellular distribution. , 2015, Human molecular genetics.
[539] D. Holtzman,et al. Neuronal activity regulates extracellular tau in vivo , 2014, The Journal of experimental medicine.
[540] Céline Héraud,et al. Levels of kinesin light chain and dynein intermediate chain are reduced in the frontal cortex in Alzheimer’s disease: implications for axoplasmic transport , 2011, Acta Neuropathologica.
[541] A. Gutiérrez,et al. Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration , 2016, Acta Neuropathologica.
[542] J. Wegiel,et al. Phosphorylation of Microtubule-associated Protein Tau Is Regulated by Protein Phosphatase 2A in Mammalian Brain , 2000, The Journal of Biological Chemistry.
[543] P. Verstreken,et al. Synaptic Contacts Enhance Cell-to-Cell Tau Pathology Propagation. , 2015, Cell reports.
[544] K. Ye,et al. SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination , 2014, Proceedings of the National Academy of Sciences.
[545] Peter Holmans,et al. A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin , 2016, Neurobiology of Aging.
[546] D. Geschwind,et al. Degradation of tau protein by puromycin-sensitive aminopeptidase in vitro. , 2006, Biochemistry.
[547] D. Zheng,et al. DnaJ/Hsc70 chaperone complexes control the extracellular release of neurodegenerative‐associated proteins , 2016, The EMBO journal.
[548] R. Ravid,et al. Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice* , 2005, Journal of Biological Chemistry.
[549] B. Ebert,et al. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia , 2016, Nature Reviews Cancer.
[550] T. Gómez-Isla,et al. A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo , 2009, Neurobiology of Disease.
[551] E. Mandelkow,et al. Mutations of Tau Protein in Frontotemporal Dementia Promote Aggregation of Paired Helical Filaments by Enhancing Local β-Structure* , 2001, The Journal of Biological Chemistry.
[552] Bill Bynum,et al. Lancet , 2015, The Lancet.
[553] R. Barker,et al. The role of tau in the pathological process and clinical expression of Huntington’s disease , 2015, Brain : a journal of neurology.